Atorvastatin Cyclic 1,3-Oxazine (Isopropyl) Methyl Ester Impurity
✓
データの正確性100%
24時間年中無休の科学サポート
⬡
品質に対する妥協ゼロ

在庫拠点

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* 在庫状況によります

Documentation

MSDSをダウンロード

サンプルCOAをダウンロード

内容: HPLC、MASS/LC-MS、1H NMR、FT-IR、含量、構造解析レポート(SER)、および製品に応じた追加分析データ。

Atorvastatin Cyclic 1,3-Oxazine (Isopropyl) Methyl Ester Impurity

● 在庫あり

カタログ番号:VE0026709
CAS番号:N/A
分子式:C34H37FN2O7
分子量:604.7 g/mol

に関する追加情報

親薬物

Atorvastatin

IUPAC名

Methyl 4-[5-(4-fluorophenyl)-5-hydroxy-4-phenyl-2-(phenylcarbamoyl)-1-propan-2-yl-3,10-dioxa-6-azatricyclo[4.4.0.02,4]decan-9-yl]-3-hydroxybutanoate

Pharmacopeial Synonyms

N/A

同義語

N/A

SMILES

O=C(OC)CC(O)CC1CCN(C(C2=CC=C(F)C=C2)(O)C3(C4=CC=CC=C4)C5(C(NC6=CC=CC=C6)=O)O3)C5(C(C)C)O1

InChI

InChI=1S/C34H37FN2O7/c1-22(2)34-32(30(40)36-26-12-8-5-9-13-26)31(44-32,23-10-6-4-7-11-23)33(41,24-14-16-25(35)17-15-24)37(34)19-18-28(43-34)20-27(38)21-29(39)42-3/h4-17,22,27-28,38,41H,18-21H2,1-3H3,(H,36,40)

説明

Atorvastatin Cyclic 1,3-Oxazine (Isopropyl) Methyl Ester Impurity is a process-related impurity featuring a cyclized 1,3-oxazine ring with an isopropyl methyl ester substituent that can form through intramolecular cyclization or unintended esterification during synthesis or storage. Effective characterization relies on HPLC for quantitation, LC-MS for molecular weight confirmation, and NMR for definitive structural assignment, supporting impurity profiling and specification development. Mitigation strategies include reaction parameter optimization, targeted purification such as preparative chromatography, and accelerated stability studies to monitor formation pathways. Robust identification and quantitation are critical for quality control, regulatory submissions, and risk assessment in atorvastatin manufacture.

見積もり依頼

「*」は必須フィールドを示します

このフィールドは入力チェック用です。変更しないでください。
Products quotation
Name
Url